Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Uridine-5'-Diphosphoglucose Disodium Salt

    • Product Name Uridine-5'-Diphosphoglucose Disodium Salt
    • Alias UDP-Glucose
    • Einecs 214-715-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    868940

    Product Name Uridine-5'-Diphosphoglucose Disodium Salt
    Molecular Formula C15H22N2Na2O17P2
    Molecular Weight 612.25 g/mol
    Cas Number 27816-23-9
    Appearance White to off-white powder
    Solubility Soluble in water
    Storage Temperature -20°C
    Purity Typically ≥95%
    Synonyms UDP-glucose disodium salt, Uridine diphosphate glucose disodium salt
    Ec Number 248-698-5
    Chemical Class Nucleotide sugar
    Ph Value Solution 7.0 (50 mg/mL in water)

    As an accredited Uridine-5'-Diphosphoglucose Disodium Salt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Uridine-5'-Diphosphoglucose Disodium Salt, 1g, is supplied in a tightly-sealed amber glass vial with a printed product label.
    Shipping Uridine-5'-Diphosphoglucose Disodium Salt is shipped at room temperature as a stable, non-hazardous solid. It is securely packaged in airtight containers to protect from moisture and light. Standard delivery methods are used, with expedited shipping available upon request. Detailed documentation and safety data sheets accompany every shipment for reference.
    Storage Uridine-5'-Diphosphoglucose Disodium Salt should be stored tightly sealed at -20°C in a dry, dark environment. Protect the compound from moisture, excessive heat, and light exposure. For optimal stability, avoid repeated freeze-thaw cycles. Ensure storage in a designated chemical refrigerator or freezer and clearly label the container. Follow all appropriate chemical safety guidelines when handling and storing the material.
    Application of Uridine-5'-Diphosphoglucose Disodium Salt

    Applications of Uridine-5'-Diphosphoglucose Disodium Salt in Industrial Manufacturing

    Uridine-5'-Diphosphoglucose Disodium Salt serves as a specialized nucleotide sugar widely adopted in core biosynthesis pathways, particularly in the enzymatic and cell-based production environments of biopharmaceutical, diagnostic, and food ingredient facilities. Our supply meets the rigorous purity, traceability, and reproducibility expectations for industrial scale and R&D use alike. Explore practical use cases where this compound delivers proven functional value along the entire downstream value chain.

    1. Enzymatic Glycosylation in API Manufacturing

    This salt is critical as a glycosyl donor in the chemoenzymatic synthesis of nucleotide-activated glycosides for active pharmaceutical ingredient (API) processes. It enables precise enzymatic attachment of glucose moieties during biocatalytic modifications, producing glycoconjugates with improved pharmacological properties for drugs targeting rare diseases and oncology therapies.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • European Pharmacopoeia 2.2.31, 2.6.7 (endotoxins and sterile substances)
    • US FDA 21 CFR 210/211 (Factory QC & Compliance)
    • ISO 9001:2015 Quality Management Systems

    Typical usage ratio

    • 0.05–0.2 molar equivalents relative to acceptor substrate; adjusted batchwise based on substrate stoichiometry and glycosyltransferase enzyme activity

    Downstream process integration

    • Added during glycosylation reaction stage; purified intermediates further react or undergo downstream chemical transformations before final isolation

    Final product types

    • Nucleotide-activated glycoconjugate APIs
    • Orphan drug precursors (e.g., carbohydrate-based therapeutics)
    • Modified nucleoside analog drugs

    2. Diagnostic Oligosaccharide Synthesis

    Specialty diagnostic reagent manufacturers rely on this compound as a UDP-glucose donor for controlled construction of oligosaccharide probes, used in in vitro diagnostic (IVD) kits for blood group typing assays and glycan analysis panels. High-purity grades are essential to ensure accurate molecular recognition in immunochemical workflows.

    Industry compliance standards

    • ISO 13485:2016 (Medical Devices & IVD Quality Management)
    • EU Regulation 2017/746 (IVDR for in vitro diagnostics)
    • CLSI GP44 (IVD reagent quality)

    Typical usage ratio

    • 0.1–1.5 mmol per synthesis, ratio varies according to oligosaccharide chain length and batch size

    Downstream process integration

    • Enters at the initial monosaccharide activation stage of automated glycan assembly; excess removed before conjugation to probe or microarray support

    Final product types

    • IVD oligosaccharide antigen kits (e.g., ABO and Lewis antigen detection)
    • Carbohydrate microarrays for biomarker identification
    • Enzyme-linked glycan probes for clinical diagnostics

    3. Biotechnological Production of Glycosylated Food Additives

    Food ingredient blenders and flavor houses use this raw material in microbial or cell-free enzymatic systems to biosynthesize glycosylated sweeteners and dietary fiber precursors, supporting the production of enhanced flavoring agents and nutritional compounds. Facility QA requires food contact compliance throughout scale-up.

    Industry compliance standards

    • EU Food Additive Regulation (EC) No. 1333/2008
    • US FDA GRAS (21 CFR 184.1835 for enzyme-modified food ingredients)
    • FSSC 22000 Food Safety Management

    Typical usage ratio

    • 0.05–0.12% w/w in total reaction media, based on carbohydrate precursor mass; varies depending on system yield and enzyme performance

    Downstream process integration

    • Fed into the glycosylation reactor with target substrate; products collected during post-reaction isolation and purification for final formulation

    Final product types

    • Glycosylated steviol glycosides (high-intensity natural sweeteners)
    • Soluble dietary fiber preparations
    • Modified flavor glycosides for beverages or functional foods

    4. Glycoengineering of Therapeutic Proteins

    Biologics manufacturing sites employ the material as a nucleotide sugar substrate in in vitro or ex vivo post-translational glycan remodeling of monoclonal antibodies and recombinant proteins. The glycoengineering workflow improves product uniformity and modulates immune recognition, critical in biosimilar and next-generation biologic production.

    Industry compliance standards

    • ICH Q5E (Comparability of Biotechnological/Biological Products)
    • US FDA Guidance for Industry: Process Validation for Biological Products
    • EU GMP Annex 2 (Manufacture of Biological Substances)
    • USP <1047> (Biotechnology-Derived Articles)

    Typical usage ratio

    • 0.05–0.15% w/v in reaction buffer; optimized depending on desired glycan coverage and protein substrate amount

    Downstream process integration

    • Introduced following protein expression and purification; glycan engineering proceeds in batch or continuous reactors, followed by QC and formulation

    Final product types

    • Monoclonal antibody therapeutics with modified glycan patterns
    • Glyco-optimized biosimilar drugs
    • Engineered recombinant enzymes for infusion therapy

    5. Biocatalytic Synthesis of Rare Sugar Derivatives

    Industrial carbohydrate producers apply this raw material to enzymatically generate rare sugar glucosides—including UDP-linked intermediates—using proprietary glycosyltransferase platforms. These rare compounds serve as precursors in pharmaceutical, cosmetic, and nutraceutical ingredient chains that depend on selective glycosylation.

    Industry compliance standards

    • ISO 22000:2018 Food Safety Management (for edible products)
    • REACH Regulation (EC) No. 1907/2006 for chemical safety
    • US Pharmacopoeia compliance for sugar derivatives entering drug products

    Typical usage ratio

    • 0.02–0.08 molar equivalents per substrate, refined based on enzyme specificity and target yield

    Downstream process integration

    • Mixed into the enzyme reactor during sugar derivative assembly; intermediate output may be diverted for multi-step synthesis workflows or bulk production

    Final product types

    • Rare UDP-sugar intermediates
    • Cosmetic oligosaccharide additives
    • Functionalized excipients for pharmaceuticals
    Free Quote

    Competitive Uridine-5'-Diphosphoglucose Disodium Salt prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Uridine-5'-Diphosphoglucose Disodium Salt: Consistency Rooted in Expertise

    About Uridine-5'-Diphosphoglucose Disodium Salt

    Working in chemical synthesis for over two decades, direct handling of uridine-5'-diphosphoglucose disodium salt has highlighted the real importance of reproducibility, batch reliability, and the right technical support. This product, often called UDP-glucose disodium salt, has become a staple for many biologically intensive processes. Its CAS number usually draws the attention of biochemists running enzymatic glycosylation reactions, and our team has been fielding increasing questions about what sets our materials apart from the lab supply chains typically used by universities and contract manufacturers.

    UDP-glucose disodium salt belongs to the family of nucleotide sugars, and its role supporting glycosyltransferase assays is well documented in enzyme-catalyzed research. Our manufacturing lines have prioritized high-purity, endotoxin-tested material for these delicate biochemical manipulations, where any contamination or variability in salt counterions easily throws off measurements and conversions. We have navigated past the inconsistencies that plagued earlier UDP-glucose sourcing, especially coming from fragmented suppliers whose material would sometimes carry traces of phosphate, free uridine, or unusual water levels. Over the years, purification steps have been tightened and product qualification has included direct collaboration with academic and industrial partners seeking precise glucose donor behavior.

    Specifications and Product Quality

    Model variations usually respond to the need for differing purities and forms of crystallization. Several firms ask for a clear, colorless powder with solubility in water at standard room temperatures. Reliable batches require strict control of sodium ion concentration, as it affects sample preparation in kinetics studies and downstream biomanufacturing. We maintain HPLC and NMR monitoring for each lot, confirming the hexose and uridine moieties' integration without notable decomposition. Final packaging relies on moisture-resistant bottles or foil-sealed bags, as even trace humidity leads to caking and, over long periods, can encourage microbial growth depending on handling.

    Weight consistency between bottles is a real concern. Scales in our facility undergo frequent calibration, and manual cross-checks stand alongside automated dispensing lines. The details behind seemingly small adjustments—like ambient humidity control and rapid transfer from crystallizer to packaging—are shaped by years responding to customers who struggled to dissolve third-party UDP-glucose and found ambiguous results in their assays. We learned that simply offering a high assay percentage does not guarantee suitability for all research, especially where enzyme inhibitors or by-products sneak in due to metabolic side-reactions. That is why our QC stretches beyond what’s typical—detecting and quantifying potential contaminants down to sub-ppm is a standard part of every run. In fact, one investigation into stubborn changes in glycosylation rate traced back to a persistent, hard-to-measure magnesium salt impurity that originated from a competitor’s process water, underscoring the need for vigilance.

    Real-World Experience Working With UDP-Glucose

    Our technical teams consult directly with customers at pharmaceutical plants, research universities, and diagnostics companies. A recurring discussion involves solubility, as certain enzyme systems fail completely when an extra sodium equivalent shows up or precipitates form unexpectedly. Even a few dozen parts-per-million of free sodium or potassium triggers disruption in their buffers. Adjusting our processes required investment well above industry minimums, but the results show up in reduced lot-to-lot variation and more robust customer publications. Those improvements matter most to researchers who base their project milestones on enzyme-conversion rates or reliable glycosylation product yields.

    Clients have shared detailed feedback on how UDP-glucose impacts substrate turnover in glucosyltransferase cascades, especially in large-scale oligosaccharide synthesis. Some ran into bottlenecks with previous sources—reaction rates dropped, or yields plummeted thanks to trace contaminants altering the course of the enzyme. By tightening purification and choosing sodium over ammonium as the counterion, we provided a product that aligns with GMP guidelines. Additionally, we’ve partnered with academic labs to troubleshoot peculiar artifacts in mass spectrometry profiles, ultimately zeroing in on the salt’s role in preserving enzyme conformational integrity.

    Usage and Best Practices

    UDP-glucose disodium salt features in a wide stretch of work, from metabolic research and glycobiology to diagnostics and material-biology crossover studies. We supply batches large enough for fermenters, as well as research-grade material for daily analytical runs. Dissolution practices vary—some projects start with pure, deionized water, mixing under nitrogen, while others drop in the salt after pH adjustment. Our batches dissolve quickly with gentle swirling, but we caution against excessive heating as some research groups have reported modest degradation at temperatures above 50° Celsius. We encourage customers to filter after solution formation, since dust or insoluble particles can appear if bottles have been stored improperly in humid climates.

    Routine shipping moves via overnight or cold chain services, which arise from several incidents where extended stays on loading docks led to physical caking or slow hydrolysis, particularly for research consortia in tropical zones. Projects that store open bottles in high-humidity environments see accelerated clumping—so timely resealing and dry storage make a measurable difference. Refreezing or repeated thawing is avoided; our product remains stable for months at 2–8°C in sealed packaging, allowing for consistent project scheduling. Whenever a researcher runs into solubility concerns, we look back at the true handling chain, since environmental factors outside manufacturing affect user perception more often than suspected. Our support group reviews these exposures regularly, closing the gap between bench and supplier.

    Differences From Other Products

    Most differences between our UDP-glucose disodium salt and alternatives on the market become obvious under close scientific scrutiny. Customers mention granularity, powder color, and reproducible reactivity as early indicators of quality. The presence of off-white shades or visible clumps suggests incomplete drying or poor crystallization during manufacture. We keep crystalline structure uniform by controlling the cooling rate during precipitation, and our comprehensive drying cycle avoids leaving residual solvents that interfere with sensitive biological reactions.

    Some commercial supplies cut corners—sourcing semi-purified intermediates or mixing materials from several production lines to fill demand. We never mix lots to fill a batch. From fermentation or chemical synthesis, each lot is traced and recorded, with end-to-end history audited to meet regulatory standards. This transparency in sourcing yields fewer surprises during downstream use. It once came up during a forensic audit for a pharmaceutical partner, tracking the root of an unexpected inhibition effect to a substance from a mixed-batch lot used by another provider. Singular batch production closes the loop on these issues.

    Technical differences often translate to measurable performance in research environments. With our salt, enzyme kinetic plots fit expected curves more reliably. One academic consortium found their glycosylation panel success rate jumped after moving away from generic UDP-glucose. These researchers cited less unexplained inhibition and a drop in side reactions. Most glycosyltransferases behave more predictably with a pure, well-characterized sugar nucleotide substrate; minor contaminants can mask, distort, or flat-out block key research results. As a result, we avoid cost-cutting steps that would compromise the biological profile of UDP-glucose.

    Commitment to Support and Education

    Specifying and sourcing a specialized product like this is about details, not paperwork. Purchasing teams regularly consult our chemists on choice of grades, packaging options, and proper in-lab handling. We have learned to talk through the specifics of every application—from ATP-coupled enzymatic studies in metabolic engineering to biocatalyst evaluation for industrial carbohydrate synthesis. Customers aren’t just troubleshooting—many push our support networks for training on storage, dissolution, and avoiding cross-contamination. Our technical literature includes case studies, but direct consultation with chemists makes the biggest difference for many labs short on time or stepping into substrate-specific experimentation.

    We invest in regular follow-up after shipment. Our technical bench runs parallel checks with each new setting, using input from bulk buyers and bench top users alike. Reports from contract research organizations usually point toward favorable batch performance, but we scrutinize this by checking return samples, running side-by-side stability trials, and even taking part in customer’s troubleshooting meetings. Direct ties between manufacturer and scientist matter much more than repeatedly passing samples through traders or generic resellers, who often can’t trace the root cause of a research anomaly.

    Ongoing Development and Process Improvements

    Product refinement didn’t stop after we established a steady supply. We continue to engage with labs at the cutting edge of carbohydrate chemistry, where new glycosyltransferases demand substrates with tighter tolerances. Our R&D wing pushes detection of micro-contaminants to new lows. Testing for metallic residues stretches above regulatory recommendations, driven not by audit but by real-world feedback. Some research unexpectedly traced aberrant glycoprotein fragmentation patterns to microgram-per-kilo levels of nickel, despite passing standard commercial specs. As those results appeared in research papers, we revisited equipment cleaning and rinsing, adding analytical oversight to detect these outliers before they leave our facility.

    We also review packaging formats based on workflow feedback. Multi-layer vacuum seals and moisture-indicator strips responded to practical storage struggles encountered by high-throughput users in humid climates. Over time, we added batch-specific QR code tracking. This lets researchers access detailed origin, analysis documentation, and usage tip sheets right from their phone or device in the lab. Product transparency and ease-of-use keep the material moving efficiently from storeroom to assay bench.

    Each improvement takes shape through shared experience. Long planning cycles align with the scale-up needs of industrial users, while rapid support stays crucial for new projects tackling next-generation glycan target synthesis. These connections run deeper than any single sales cycle, and support the continuous improvement valued by bioprocess specialists in academia and industry.

    Challenges and Solutions in the UDP-Glucose Supply Chain

    Manufacturing UDP-glucose with strict purity isn’t straightforward. Large upstream suppliers sometimes fluctuate in schedule, pushing us to develop backup fermentation routes and implement buffer stocks for critical reagents. We faced logistical bottlenecks in global shipping, especially with regulatory changes affecting chemical import and export. Solutions came from local warehousing near major research hubs and investing in redundant supply streams for all key raw materials. By planning quarterly rather than annually, we’ve smoothed out shocks in order timing and avoided price spikes that often hit spot-market or unplanned purchases.

    Regulatory inconsistencies across markets drove us to produce detailed supporting technical documents and test reports. This effort occasionally frustrates paperwork-weary project managers, but proves worthwhile during audits and batch recalls elsewhere in the market. We offer targeted webinars and remote training, helping partners keep their registrations compliant and resolve discrepancies between product labeling formats in different countries. Past industry audits flagged inadequate chain of custody and incomplete batch documentation, leading us to harden our tracking protocols and keep samples from every lot, archived for post-market comparison against actual research outcomes.

    Many users struggle with mislabeling or unclear counterion concentrations in generic UDP-glucose sources, risking invalidation of valuable results. Our technical service teams actively compare our salt content and hydration state with those of parallel supplies, often identifying subtle but crucial differences in mass, counterion type, or packing medium. Direct consultation bridges communication gaps and remedies misunderstandings early on. By sharing full analytical spectra under confidentiality where appropriate, we empower customers to verify and audit the purchased material.

    Building for Tomorrow

    We recognize that supplying a core nucleotide sugar isn’t just about delivering a box on a loading dock. Every improvement comes straight from user feedback, our own lessons from the hard-won manufacturing process, and a shared commitment to advancing biochemical knowledge. UDP-glucose disodium salt enables a range of breakthrough work, from glycoprotein engineering and cell-surface modification to advanced metabolism studies. Our reputation in this space rests on continuous vigilance, open communication with customers, and a refusal to cut corners that might threaten the integrity of tomorrow’s science.

    Building reliable supply means investing in the people and processes behind each bottle. Long-tenured chemists oversee each batch, and our scale-up engineers stay in close touch with bench scientists to adapt operations as project needs shift. This ongoing engagement fuels process improvement and encourages a culture where safety, reliability, and technical innovation thrive side-by-side. In this spirit, we remain dedicated to providing UDP-glucose products that meet—and often exceed—the standards demanded by leading researchers and industry partners around the world.